Skip to main content

Serum Institute of India buys Czech Republic’s Nanotherapeutics

Geneva 26 April 2017 – One of the largest vaccine manufacturer globally, the Serum Institute of India (SII), has acquired Czech biopharma company from Nanotherapeutics for 72 million euros, announced Dr. Cyrus Poonawalla today.

This acquisition will add to SII group injectable Polio capacity, increasing it by 4 times to a total of 200 million doses by 2019, making SII the largest injectable non-oral Polio vaccine manufacturer in the world. The plant at Bohumil, which is one hour off the Czech Republic capital Prague, is not functional now.

The media reports have quoted the deal at €72 million, however, there has been no official confirmation over the cost from the company.

More information available at

Attached documents